Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis

Clinical trial NCT01451203 · COMPLETED

Trial details

NCT number: NCT01451203
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2011-10-11
Primary completion: 2013-08-28
Enrollment: 319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.